Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations.

Authors

Brian Haymart
Geoffrey D Barnes
Xiaowen Kong
Mona Ali, Beaumont Health
Eva Kline-Rogers
Deborah DeCamillo
Scott Kaatz

Document Type

Article

Publication Date

7-1-2022

Publication Title

JAMA Network Open

Abstract

This cohort study evaluates stroke and major bleeding rates before and after switching from warfarin to a direct oral anticoagulant (DOAC) in patients grouped by pre-switch time-in-therapeutic range guideline thresholds.

Volume

5

Issue

7

First Page

2222089

Last Page

2222089

Recommended Citation

Haymart B, Barnes GD, Kong X, Ali M, Kline-Rogers E, DeCamillo D, et al Comparison of patient outcomes before and after switching from warfarin to a direct oral anticoagulant based on time in therapeutic range guideline recommendations. JAMA Netw Open. 2022 Jul 1;5(7):e2222089. doi: 10.1001/jamanetworkopen.2022.22089. PMID: 35834255.

DOI

10.1001/jamanetworkopen.2022.22089

ISSN

2574-3805

PubMed ID

35834255